AngioDynamics, Inc.
ANGO
$10.94
$0.282.63%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 313.73M | 307.31M | 300.72M | 292.50M | 283.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 313.73M | 307.31M | 300.72M | 292.50M | 283.32M |
| Cost of Revenue | 143.39M | 139.59M | 137.88M | 134.79M | 129.32M |
| Gross Profit | 170.34M | 167.72M | 162.84M | 157.71M | 154.00M |
| SG&A Expenses | 152.84M | 150.62M | 149.69M | 145.60M | 143.91M |
| Depreciation & Amortization | 10.55M | 10.48M | 10.40M | 10.32M | 10.30M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 334.18M | 327.98M | 323.97M | 316.56M | 309.55M |
| Operating Income | -20.45M | -20.67M | -23.25M | -24.06M | -26.23M |
| Income Before Tax | -31.38M | -27.71M | -32.21M | -34.03M | -42.06M |
| Income Tax Expenses | 12.00K | -2.00K | -107.00K | -39.00K | -671.00K |
| Earnings from Continuing Operations | -31.39 | -27.71 | -32.10 | -33.99 | -41.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.39M | -27.71M | -32.10M | -33.99M | -41.39M |
| EBIT | -20.45M | -20.67M | -23.25M | -24.06M | -26.23M |
| EBITDA | -659.00K | -150.00K | -1.61M | -1.66M | -1.85M |
| EPS Basic | -0.76 | -0.67 | -0.78 | -0.83 | -1.02 |
| Normalized Basic EPS | -0.25 | -0.24 | -0.27 | -0.28 | -0.30 |
| EPS Diluted | -0.76 | -0.68 | -0.79 | -0.84 | -1.02 |
| Normalized Diluted EPS | -0.25 | -0.24 | -0.27 | -0.28 | -0.30 |
| Average Basic Shares Outstanding | 165.30M | 164.55M | 163.93M | 163.41M | 162.86M |
| Average Diluted Shares Outstanding | 165.30M | 164.55M | 163.93M | 163.41M | 162.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |